カテゴリー： LP Information, 世界, 部品/材料

世界のイオヘキソール市場予測 2021年-2026年

【英語タイトル】Global Iohexol (CAS 66108-95-0) Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY2604）・商品コード：LPI21MY2604
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：137
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「イオヘキソールの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、0.99、0.98、その他など、用途別には、造影剤、診断剤、その他などにセグメント区分してまとめました。イオヘキソールのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・イオヘキソールの世界市場概要（サマリー）
・イオヘキソールの企業別販売量・売上
・イオヘキソールの企業別市場シェア
・イオヘキソールの世界市場規模 2016年-2021年：種類別（0.99、0.98、その他）
・イオヘキソールの世界市場規模 2016年-2021年：用途別（造影剤、診断剤、その他）
・イオヘキソールの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・イオヘキソールのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・イオヘキソールのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・イオヘキソールの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・イオヘキソール市場の成長要因・課題・動向
・イオヘキソールの世界市場予測 2021年-2026年
・イオヘキソールの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・イオヘキソールのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・イオヘキソールのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・イオヘキソールの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・イオヘキソールの世界市場予測：種類別（0.99、0.98、その他）
・イオヘキソールの世界市場予測：用途別（造影剤、診断剤、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Iohexol (CAS 66108-95-0) will have significant change from previous year. By the most conservative estimates of global Iohexol (CAS 66108-95-0) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Iohexol (CAS 66108-95-0) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Iohexol (CAS 66108-95-0) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
0.99
0.98
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Contrast Agents
Diagnostic Agents
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zhejiang Hichi Pharmaceutical
Chengdu Laurelsci
Dr.Ehrenstorfer
Shanghai Shucan
Zhejiang Hisyn Pharmaceutical
Zhejiang Starry Pharmaceutical
Interpharma Praha

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Iohexol (CAS 66108-95-0) Consumption 2016-2026
2.1.2 Iohexol (CAS 66108-95-0) Consumption CAGR by Region
2.2 Iohexol (CAS 66108-95-0) Segment by Type
2.2.1 0.99
2.2.2 0.98
2.2.3 Others
2.3 Iohexol (CAS 66108-95-0) Sales by Type
2.3.1 Global Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
2.3.2 Global Iohexol (CAS 66108-95-0) Revenue and Market Share by Type (2016-2021)
2.3.3 Global Iohexol (CAS 66108-95-0) Sale Price by Type (2016-2021)
2.4 Iohexol (CAS 66108-95-0) Segment by Application
2.4.1 Contrast Agents
2.4.2 Diagnostic Agents
2.4.3 Others
2.5 Iohexol (CAS 66108-95-0) Sales by Application
2.5.1 Global Iohexol (CAS 66108-95-0) Sale Market Share by Application (2016-2021)
2.5.2 Global Iohexol (CAS 66108-95-0) Revenue and Market Share by Application (2016-2021)
2.5.3 Global Iohexol (CAS 66108-95-0) Sale Price by Application (2016-2021)

3 Global Iohexol (CAS 66108-95-0) by Company
3.1 Global Iohexol (CAS 66108-95-0) Sales Market Share by Company
3.1.1 Global Iohexol (CAS 66108-95-0) Sales by Company (2019-2021)
3.1.2 Global Iohexol (CAS 66108-95-0) Sales Market Share by Company (2019-2021)
3.2 Global Iohexol (CAS 66108-95-0) Revenue Market Share by Company
3.2.1 Global Iohexol (CAS 66108-95-0) Revenue by Company (2019-2021)
3.2.2 Global Iohexol (CAS 66108-95-0) Revenue Market Share by Company (2019-2021)
3.3 Global Iohexol (CAS 66108-95-0) Sale Price by Company
3.4 Global Manufacturers Iohexol (CAS 66108-95-0) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iohexol (CAS 66108-95-0) Product Location Distribution
3.4.2 Players Iohexol (CAS 66108-95-0) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Iohexol (CAS 66108-95-0) by Region
4.1 Global Iohexol (CAS 66108-95-0) by Region
4.1.1 Global Iohexol (CAS 66108-95-0) Sales by Region
4.1.2 Global Iohexol (CAS 66108-95-0) Revenue by Region
4.2 Americas Iohexol (CAS 66108-95-0) Sales Growth
4.3 APAC Iohexol (CAS 66108-95-0) Sales Growth
4.4 Europe Iohexol (CAS 66108-95-0) Sales Growth
4.5 Middle East & Africa Iohexol (CAS 66108-95-0) Sales Growth

5 Americas
5.1 Americas Iohexol (CAS 66108-95-0) Sales by Country
5.1.1 Americas Iohexol (CAS 66108-95-0) Sales by Country (2016-2021)
5.1.2 Americas Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021)
5.2 Americas Iohexol (CAS 66108-95-0) Sales by Type
5.3 Americas Iohexol (CAS 66108-95-0) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Iohexol (CAS 66108-95-0) Sales by Region
6.1.1 APAC Iohexol (CAS 66108-95-0) Sales by Region (2016-2021)
6.1.2 APAC Iohexol (CAS 66108-95-0) Revenue by Region (2016-2021)
6.2 APAC Iohexol (CAS 66108-95-0) Sales by Type
6.3 APAC Iohexol (CAS 66108-95-0) Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Iohexol (CAS 66108-95-0) by Country
7.1.1 Europe Iohexol (CAS 66108-95-0) Sales by Country (2016-2021)
7.1.2 Europe Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021)
7.2 Europe Iohexol (CAS 66108-95-0) Sales by Type
7.3 Europe Iohexol (CAS 66108-95-0) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Iohexol (CAS 66108-95-0) by Country
8.1.1 Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Country (2016-2021)
8.1.2 Middle East & Africa Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021)
8.2 Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Type
8.3 Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Iohexol (CAS 66108-95-0) Distributors
10.3 Iohexol (CAS 66108-95-0) Customer

11 Global Iohexol (CAS 66108-95-0) Market Forecast
11.1 Global Iohexol (CAS 66108-95-0) Forecast by Region
11.1.1 Global Iohexol (CAS 66108-95-0) Forecast by Regions (2021-2026)
11.2.2 Global Iohexol (CAS 66108-95-0) Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Iohexol (CAS 66108-95-0) Forecast by Type
11.7 Global Iohexol (CAS 66108-95-0) Forecast by Application

12 Key Players Analysis
12.1 Zhejiang Hichi Pharmaceutical
12.1.1 Zhejiang Hichi Pharmaceutical Zhejiang Hichi Pharmaceutical Company Information
12.1.2 Zhejiang Hichi Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
12.1.3 Zhejiang Hichi Pharmaceutical Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zhejiang Hichi Pharmaceutical Main Business Overview
12.1.5 Zhejiang Hichi Pharmaceutical Latest Developments
12.2 Chengdu Laurelsci
12.2.1 Chengdu Laurelsci Company Information
12.2.2 Chengdu Laurelsci Iohexol (CAS 66108-95-0) Product Offered
12.2.3 Chengdu Laurelsci Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Chengdu Laurelsci Main Business Overview
12.2.5 Chengdu Laurelsci Latest Developments
12.3 Dr.Ehrenstorfer
12.3.1 Dr.Ehrenstorfer Company Information
12.3.2 Dr.Ehrenstorfer Iohexol (CAS 66108-95-0) Product Offered
12.3.3 Dr.Ehrenstorfer Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Dr.Ehrenstorfer Main Business Overview
12.3.5 Dr.Ehrenstorfer Latest Developments
12.4 Shanghai Shucan
12.4.1 Shanghai Shucan Company Information
12.4.2 Shanghai Shucan Iohexol (CAS 66108-95-0) Product Offered
12.4.3 Shanghai Shucan Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Shanghai Shucan Main Business Overview
12.4.5 Shanghai Shucan Latest Developments
12.5 Zhejiang Hisyn Pharmaceutical
12.5.1 Zhejiang Hisyn Pharmaceutical Company Information
12.5.2 Zhejiang Hisyn Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
12.5.3 Zhejiang Hisyn Pharmaceutical Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Zhejiang Hisyn Pharmaceutical Main Business Overview
12.5.5 Zhejiang Hisyn Pharmaceutical Latest Developments
12.6 Zhejiang Starry Pharmaceutical
12.6.1 Zhejiang Starry Pharmaceutical Company Information
12.6.2 Zhejiang Starry Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
12.6.3 Zhejiang Starry Pharmaceutical Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zhejiang Starry Pharmaceutical Main Business Overview
12.6.5 Zhejiang Starry Pharmaceutical Latest Developments
12.7 Interpharma Praha
12.7.1 Interpharma Praha Company Information
12.7.2 Interpharma Praha Iohexol (CAS 66108-95-0) Product Offered
12.7.3 Interpharma Praha Iohexol (CAS 66108-95-0) Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Interpharma Praha Main Business Overview
12.7.5 Interpharma Praha Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Iohexol (CAS 66108-95-0) Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 0.99
Table 3. Major Players of 0.98
Table 4. Major Players of Others
Table 5. Global Iohexol (CAS 66108-95-0) Sales by Type (2016-2021) & (MT)
Table 6. Global Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
Table 7. Global Iohexol (CAS 66108-95-0) Revenue by Type (2016-2021) & ($ million)
Table 8. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Type (2016-2021)
Table 9. Global Iohexol (CAS 66108-95-0) Sale Price by Type (2016-2021)
Table 10. Global Iohexol (CAS 66108-95-0) Sales by Application (2016-2021) & (MT)
Table 11. Global Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Table 12. Global Iohexol (CAS 66108-95-0) Value by Application (2016-2021)
Table 13. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Application (2016-2021)
Table 14. Global Iohexol (CAS 66108-95-0) Sale Price by Application (2016-2021)
Table 15. Global Iohexol (CAS 66108-95-0) Sales by Company (2019-2021) & (MT)
Table 16. Global Iohexol (CAS 66108-95-0) Sales Market Share by Company (2019-2021)
Table 17. Global Iohexol (CAS 66108-95-0) Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Company (2019-2021)
Table 19. Global Iohexol (CAS 66108-95-0) Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Iohexol (CAS 66108-95-0) Producing Area Distribution and Sales Area
Table 21. Players Iohexol (CAS 66108-95-0) Products Offered
Table 22. Iohexol (CAS 66108-95-0) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Iohexol (CAS 66108-95-0) Sales by Region (2016-2021) (MT)
Table 26. Global Iohexol (CAS 66108-95-0) Sales Market Share by Region (2016-2021)
Table 27. Global Iohexol (CAS 66108-95-0) Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Region (2016-2021)
Table 29. Americas Iohexol (CAS 66108-95-0) Sales by Country (2016-2021) & (MT)
Table 30. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Country (2016-2021)
Table 31. Americas Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Iohexol (CAS 66108-95-0) Revenue Market Share by Country (2016-2021)
Table 33. Americas Iohexol (CAS 66108-95-0) Sales by Type (2016-2021) & (MT)
Table 34. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
Table 35. Americas Iohexol (CAS 66108-95-0) Sales by Application (2016-2021) & (MT)
Table 36. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Table 37. APAC Iohexol (CAS 66108-95-0) Sales by Region (2016-2021) & (MT)
Table 38. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Region (2016-2021)
Table 39. APAC Iohexol (CAS 66108-95-0) Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Iohexol (CAS 66108-95-0) Revenue Market Share by Region (2016-2021)
Table 41. APAC Iohexol (CAS 66108-95-0) Sales by Type (2016-2021) & (MT)
Table 42. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
Table 43. APAC Iohexol (CAS 66108-95-0) Sales by Application (2016-2021) & (MT)
Table 44. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Table 45. Europe Iohexol (CAS 66108-95-0) Sales by Country (2016-2021) & (MT)
Table 46. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Country (2016-2021)
Table 47. Europe Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Iohexol (CAS 66108-95-0) Revenue Market Share by Country (2016-2021)
Table 49. Europe Iohexol (CAS 66108-95-0) Sales by Type (2016-2021) & (MT)
Table 50. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
Table 51. Europe Iohexol (CAS 66108-95-0) Sales by Application (2016-2021) & (MT)
Table 52. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Country (2016-2021) & (MT)
Table 54. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Iohexol (CAS 66108-95-0) Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Iohexol (CAS 66108-95-0) Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Type (2016-2021) & (MT)
Table 58. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Iohexol (CAS 66108-95-0) Sales by Application (2016-2021) & (MT)
Table 60. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Table 61. Global Iohexol (CAS 66108-95-0) Sales Forecast by Type (2021-2026) & (MT)
Table 62. Global Iohexol (CAS 66108-95-0) Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Iohexol (CAS 66108-95-0) Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Iohexol (CAS 66108-95-0) Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Iohexol (CAS 66108-95-0) Sales Forecast by Application (2021-2026) & (MT)
Table 66. Global Iohexol (CAS 66108-95-0) Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Iohexol (CAS 66108-95-0) Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Iohexol (CAS 66108-95-0) Revenue Market Share Forecast by Application (2021-2026)
Table 69. Zhejiang Hichi Pharmaceutical Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 70. Zhejiang Hichi Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
Table 71. Zhejiang Hichi Pharmaceutical Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 72. Zhejiang Hichi Pharmaceutical Main Business
Table 73. Zhejiang Hichi Pharmaceutical Latest Developments
Table 74. Chengdu Laurelsci Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 75. Chengdu Laurelsci Iohexol (CAS 66108-95-0) Product Offered
Table 76. Chengdu Laurelsci Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 77. Chengdu Laurelsci Main Business
Table 78. Chengdu Laurelsci Latest Developments
Table 79. Dr.Ehrenstorfer Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 80. Dr.Ehrenstorfer Iohexol (CAS 66108-95-0) Product Offered
Table 81. Dr.Ehrenstorfer Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 82. Dr.Ehrenstorfer Main Business
Table 83. Dr.Ehrenstorfer Latest Developments
Table 84. Shanghai Shucan Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 85. Shanghai Shucan Iohexol (CAS 66108-95-0) Product Offered
Table 86. Shanghai Shucan Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 87. Shanghai Shucan Main Business
Table 88. Shanghai Shucan Latest Developments
Table 89. Zhejiang Hisyn Pharmaceutical Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 90. Zhejiang Hisyn Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
Table 91. Zhejiang Hisyn Pharmaceutical Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 92. Zhejiang Hisyn Pharmaceutical Main Business
Table 93. Zhejiang Hisyn Pharmaceutical Latest Developments
Table 94. Zhejiang Starry Pharmaceutical Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 95. Zhejiang Starry Pharmaceutical Iohexol (CAS 66108-95-0) Product Offered
Table 96. Zhejiang Starry Pharmaceutical Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 97. Zhejiang Starry Pharmaceutical Main Business
Table 98. Zhejiang Starry Pharmaceutical Latest Developments
Table 99. Interpharma Praha Basic Information, Iohexol (CAS 66108-95-0) Manufacturing Base, Sales Area and Its Competitors
Table 100. Interpharma Praha Iohexol (CAS 66108-95-0) Product Offered
Table 101. Interpharma Praha Iohexol (CAS 66108-95-0) Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 102. Interpharma Praha Main Business
Table 103. Interpharma Praha Latest Developments
List of Figures
Figure 1. Picture of Iohexol (CAS 66108-95-0)
Figure 2. Iohexol (CAS 66108-95-0) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iohexol (CAS 66108-95-0) Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Iohexol (CAS 66108-95-0) Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Iohexol (CAS 66108-95-0) Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 0.99
Figure 10. Product Picture of 0.98
Figure 11. Product Picture of Others
Figure 12. Global Iohexol (CAS 66108-95-0) Sales Market Share by Type in 2020
Figure 13. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Type (2016-2021)
Figure 14. Iohexol (CAS 66108-95-0) Consumed in Contrast Agents
Figure 15. Global Iohexol (CAS 66108-95-0) Market: Contrast Agents (2016-2021) & (MT)
Figure 16. Iohexol (CAS 66108-95-0) Consumed in Diagnostic Agents
Figure 17. Global Iohexol (CAS 66108-95-0) Market: Diagnostic Agents (2016-2021) & (MT)
Figure 18. Iohexol (CAS 66108-95-0) Consumed in Others
Figure 19. Global Iohexol (CAS 66108-95-0) Market: Others (2016-2021) & (MT)
Figure 20. Global Iohexol (CAS 66108-95-0) Sales Market Share by Application (2016-2021)
Figure 21. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Application in 2020
Figure 22. Global Iohexol (CAS 66108-95-0) Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Company in 2020
Figure 24. Global Iohexol (CAS 66108-95-0) Sales Market Share by Regions (2016-2021)
Figure 25. Global Iohexol (CAS 66108-95-0) Revenue Market Share by Region in 2020
Figure 26. Americas Iohexol (CAS 66108-95-0) Sales 2016-2021 (MT)
Figure 27. Americas Iohexol (CAS 66108-95-0) Revenue 2016-2021 ($ Millions)
Figure 28. APAC Iohexol (CAS 66108-95-0) Sales 2016-2021 (MT)
Figure 29. APAC Iohexol (CAS 66108-95-0) Revenue 2016-2021 ($ Millions)
Figure 30. Europe Iohexol (CAS 66108-95-0) Sales 2016-2021 (MT)
Figure 31. Europe Iohexol (CAS 66108-95-0) Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Iohexol (CAS 66108-95-0) Sales 2016-2021 (MT)
Figure 33. Middle East & Africa Iohexol (CAS 66108-95-0) Revenue 2016-2021 ($ Millions)
Figure 34. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Country in 2020
Figure 35. Americas Iohexol (CAS 66108-95-0) Revenue Market Share by Country in 2020
Figure 36. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Type in 2020
Figure 37. Americas Iohexol (CAS 66108-95-0) Sales Market Share by Application in 2020
Figure 38. United States Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Region in 2020
Figure 43. APAC Iohexol (CAS 66108-95-0) Revenue Market Share by Regions in 2020
Figure 44. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Type in 2020
Figure 45. APAC Iohexol (CAS 66108-95-0) Sales Market Share by Application in 2020
Figure 46. China Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Country in 2020
Figure 53. Europe Iohexol (CAS 66108-95-0) Revenue Market Share by Country in 2020
Figure 54. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Type in 2020
Figure 55. Europe Iohexol (CAS 66108-95-0) Sales Market Share by Application in 2020
Figure 56. Germany Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Iohexol (CAS 66108-95-0) Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Iohexol (CAS 66108-95-0) Sales Market Share by Application in 2020
Figure 65. Egypt Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Iohexol (CAS 66108-95-0) Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のイオヘキソール市場予測 2021年-2026年] (コード：LPI21MY2604)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のイオヘキソール市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の心血管・脳血管API市場予測 2021年-2026年
    LPI21MY0941 / LP Information / 2021年5月 / LPインフォメーション社の「心血管・脳血管APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管APIなど、用途別には、経口薬、注射薬などにセグメント区分してまとめました。心血管・脳血管APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管・脳血管APIの世界市場概要（サマリー） ・心血管・脳血管APIの企業別販売量・売上 ・心血管・脳血管APIの企業別市場シェア ・心血管・脳血管APIの世界市場規模 2016年-2021年：種類別（サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管API） ・心血管・脳血管APIの世界市場規模 2016年-2021年：用途別（経口薬、注射薬） ・心血管・脳血管APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管・脳血管APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Cardiovascular and Cerebrovascular API will have significant change from previous year. By the most conservative estimates of global Cardiovascular and Cerebrovascular API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2941.1 million in 2020. Over the next five years the Cardiovascular and Cerebrovascular API market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 3282 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular and Cerebrovascular API...
  • 世界の注射用エルタペネム市場予測 2021年-2026年
    LPI21MY1305 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エルタペネムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度> 98％、純度> 99％など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。注射用エルタペネムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エルタペネムの世界市場概要（サマリー） ・注射用エルタペネムの企業別販売量・売上 ・注射用エルタペネムの企業別市場シェア ・注射用エルタペネムの世界市場規模 2016年-2021年：種類別（純度> 98％、純度> 99％）...According to this latest study, the 2021 growth of Ertapenem for Injection will have significant change from previous year. By the most conservative estimates of global Ertapenem for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ertapenem for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem for Injection market by product type,...
  • 世界のカルバペネムAPI市場予測 2021年-2026年
    LPI21MY0916 / LP Information / 2021年5月 / LPインフォメーション社の「カルバペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。カルバペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・カルバペネムAPIの世界市場概要（サマリー） ・カルバペネムAPIの企業別販売量・売上 ・カルバペネムAPIの企業別市場シェア ・カルバペネムAPIの世界市場規模 2016年-2021年：種類別（エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他） ・カルバペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射） ・カルバペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・カルバペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Carbapenem API will have significant change from previous year. By the most conservative estimates of global Carbapenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Carbapenem API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Carbapenem API market by product type, application, key manufacturers and...
  • 世界のメロペネムAPI市場予測 2021年-2026年
    LPI21MY1887 / LP Information / 2021年5月 / LPインフォメーション社の「メロペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、粗メロペネム、注射グレードメロペネムなど、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。メロペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・メロペネムAPIの世界市場概要（サマリー） ・メロペネムAPIの企業別販売量・売上 ・メロペネムAPIの企業別市場シェア ・メロペネムAPIの世界市場規模 2016年-2021年：種類別（粗メロペネム、注射グレードメロペネム） ・メロペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射） ・メロペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・メロペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Meropenem API will have significant change from previous year. By the most conservative estimates of global Meropenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Meropenem API market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem API market by product type, application, key manufacturers and...
  • 世界のパラセタモール有効成分市場予測 2021年-2026年
    LPI21MY2144 / LP Information / 2021年5月 / LPインフォメーション社の「パラセタモール有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、頭痛＆発熱、風邪＆咳、筋肉けいれん、その他などにセグメント区分してまとめました。パラセタモール有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・パラセタモール有効成分の世界市場概要（サマリー） ・パラセタモール有効成分の企業別販売量・売上 ・パラセタモール有効成分の企業別市場シェア ・パラセタモール有効成分の世界市場規模 2016年-2021年：種類別（純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）） ・パラセタモール有効成分の世界市場規模 2016年-2021年：用途別（頭痛＆発熱、風邪＆咳、筋肉けいれん、その他） ・パラセタモール有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・パラセタモール有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Paracetamol Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Paracetamol Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Paracetamol Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Paracetamol Active Pharmaceutical Ingredients...
  • 世界のR-3-THF-OL市場予測 2021年-2026年
    LPI21MY1595 / LP Information / 2021年5月 / LPインフォメーション社の「R-3-THF-OLの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度≥99％、純度...According to this latest study, the 2021 growth of R-3-THF-OL(CAS：86087-24-3) will have significant change from previous year. By the most conservative estimates of global R-3-THF-OL(CAS：86087-24-3) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the R-3-THF-OL(CAS：86087-24-3) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of R-3-THF-OL(CAS：86087-24-3) market by product type, application, key manufacturers and key regions and countries....
  • 世界の解熱鎮痛薬用有効成分市場予測 2021年-2026年
    LPI21MY0712 / LP Information / 2021年5月 / LPインフォメーション社の「解熱鎮痛薬用有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他など、用途別には、頭痛・発熱、風邪・咳、筋肉痙攣、その他などにセグメント区分してまとめました。解熱鎮痛薬用有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・解熱鎮痛薬用有効成分の世界市場概要（サマリー） ・解熱鎮痛薬用有効成分の企業別販売量・売上 ・解熱鎮痛薬用有効成分の企業別市場シェア ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：種類別（パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他） ・解熱鎮痛薬用有効成分の世界市場規模 2016年-2021年：用途別（頭痛・発熱、風邪・咳、筋肉痙攣、その他） ・解熱鎮痛薬用有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・解熱鎮痛薬用有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Antipyretic Analgesic Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Antipyretic Analgesic Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Antipyretic Analgesic Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Antipyretic...
  • 世界のS-3-THF-OL市場予測 2021年-2026年
    LPI21MY1665 / LP Information / 2021年5月 / LPインフォメーション社の「S-3-THF-OLの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度≥99％、純度...According to this latest study, the 2021 growth of S-3-THF-OL (CAS：86087-23-2) will have significant change from previous year. By the most conservative estimates of global S-3-THF-OL (CAS：86087-23-2) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the S-3-THF-OL (CAS：86087-23-2) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of S-3-THF-OL (CAS：86087-23-2) market by product type, application, key manufacturers and...
  • 世界の2-ブチン酸市場予測 2021年-2026年
    LPI21MY3092 / LP Information / 2021年5月 / LPインフォメーション社の「2-ブチン酸の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、98% 純度、 99% 純度など、用途別には、有機合成、医薬品中間体、その他などにセグメント区分してまとめました。2-ブチン酸のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・2-ブチン酸の世界市場概要（サマリー） ・2-ブチン酸の企業別販売量・売上 ・2-ブチン酸の企業別市場シェア ・2-ブチン酸の世界市場規模 2016年-2021年：種類別（98% 純度、...According to this latest study, the 2021 growth of 2-butynoic Acid will have significant change from previous year. By the most conservative estimates of global 2-butynoic Acid market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the 2-butynoic Acid market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of 2-butynoic Acid market by product type, application, key manufacturers and...
  • 世界のスピノサド市場予測 2021年-2026年
    LPI21MY2723 / LP Information / 2021年5月 / LPインフォメーション社の「スピノサドの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、スプレー、ほこり、顆粒、錠剤、懸濁液など、用途別には、農薬、研究、工業、家庭用化合物、医薬品などにセグメント区分してまとめました。スピノサドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・スピノサドの世界市場概要（サマリー） ・スピノサドの企業別販売量・売上 ・スピノサドの企業別市場シェア ・スピノサドの世界市場規模 2016年-2021年：種類別（スプレー、ほこり、顆粒、錠剤、懸濁液） ・スピノサドの世界市場規模 2016年-2021年：用途別（農薬、研究、工業、家庭用化合物、医薬品） ・スピノサドの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・スピノサドのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Spinosad will have significant change from previous year. By the most conservative estimates of global Spinosad market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Spinosad market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Spinosad market by product type, application, key manufacturers and key regions and countries....

    • ◆H&Iグローバルリサーチのお客様（例）◆